Armistice Capital, LLC 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 1,313,348 9.990% | 234,889 (+21.78%) | Filing |
| 2024-02-14 2:23 pm Purchase | 2023-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 1,078,459 9.990% | 122,464 (+12.81%) | Filing |
| 2023-02-14 12:06 pm Purchase | 2022-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 955,995 9.990% | 23,943 (+2.57%) | Filing |
| 2022-02-14 6:31 pm Purchase | 2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 932,052 9.990% | 491,308 (+111.47%) | Filing |
| 2021-02-16 5:10 pm Sale | 2020-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 440,744 8.000% | -1,309,256 (-74.81%) | Filing |